These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17882670

  • 21. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA, TOTAL Study Investigators Group.
    BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone.
    Norris LA, Brosnan J, Bonnar J, Conard J, Kluft C, Hellgren M.
    Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345
    [Abstract] [Full Text] [Related]

  • 25. Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
    Neves-E-Castro M.
    Clin Obstet Gynecol; 2008 Sep; 51(3):607-17. PubMed ID: 18677154
    [Abstract] [Full Text] [Related]

  • 26. [Vascular effects of gestagens--biochemistry versus epidemiology].
    Kuhl H.
    Zentralbl Gynakol; 1999 Sep; 121(2):67-78. PubMed ID: 10096172
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers.
    Blondon M, van Hylckama Vlieg A, Wiggins KL, Harrington LB, McKnight B, Rice KM, Rosendaal FR, Heckbert SR, Psaty BM, Smith NL.
    J Thromb Haemost; 2014 Jun; 12(6):879-86. PubMed ID: 24628832
    [Abstract] [Full Text] [Related]

  • 31. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Skouby SO, Sidelmann JJ, Nilas L, Gram J, Jespersen J.
    Climacteric; 2008 Jun; 11(6):489-97. PubMed ID: 18991076
    [Abstract] [Full Text] [Related]

  • 32. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women.
    Kwok S, Charlton-Menys V, Pemberton P, McElduff P, Durrington PN.
    Maturitas; 2006 Mar 20; 53(4):439-46. PubMed ID: 16139447
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
    Farris M, Bastianelli C, Rosato E, Brosens I, Benagiano G.
    Expert Rev Clin Pharmacol; 2017 Oct 20; 10(10):1129-1144. PubMed ID: 28712325
    [Abstract] [Full Text] [Related]

  • 35. Controversies regarding hormone therapy: Insights from inflammation and hemostasis.
    Koh KK, Yoon BK.
    Cardiovasc Res; 2006 Apr 01; 70(1):22-30. PubMed ID: 16412400
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
    Perrone G, Capri O, Galoppi P, Brunelli R, Bevilacqua E, Ceci F, Ciarla MV, Strom R.
    Gynecol Obstet Invest; 2009 Apr 01; 68(1):33-9. PubMed ID: 19349712
    [Abstract] [Full Text] [Related]

  • 39. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
    Mueck AO, Genazzani AR, Samsioe G, Vukovic-Wysocki I, Seeger H.
    Menopause; 2007 Apr 01; 14(6):978-84. PubMed ID: 17595593
    [Abstract] [Full Text] [Related]

  • 40. Less effect of intranasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal women.
    Hemelaar M, Rosing J, Kenemans P, Thomassen MC, Braat DD, van der Mooren MJ.
    Arterioscler Thromb Vasc Biol; 2006 Jul 01; 26(7):1660-6. PubMed ID: 16645152
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.